LIMINATUS PHARMA INC-CL A (LIMN) Stock Balance Sheet
NASDAQ:LIMN • US53271X1081
Current stock price
0.1952 USD
0 (-2.4%)
Last:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 724.50K | 65.30K | 156.40K | 280.60K | 300.00K | |||
| Receivables | 0.00 | 3.67M | 945.00K | 100.00K | 0.00 | |||
| Other Current Assets | 478.90K | 1.56M | 862.00K | 1.69M | 100.00K | |||
| Total Current Assets | 1.20M | 5.28M | 2.24M | 6.84M | 400.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.80K | 1.00K | 1.00K | 1.00K | N/A | |||
| Investments And Advances | N/A | 2.02M | 4.29M | 15.13M | 276.00M | |||
| Total Non-Current Assets | 139.00K | 127.00K | 1.00K | 1.00K | 276.00M | |||
| TOTAL ASSETS | 1.34M | 5.41M | 2.24M | 6.84M | 276.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.44M | 19.97M | 16.05M | 16.50M | 0.00 | |||
| Accrued Expenses | 184.90K | 1.31M | 616.00K | 441.00K | 200.00K | |||
| Accounts Payable | 559.20K | 1.48M | 2.93M | 508.00K | 1.10M | |||
| Other Current Liabilities | 678.10K | 1.98M | 437.00K | 204.00K | 100.00K | |||
| Total Current Liabilities | 2.86M | 24.75M | 18.04M | 17.65M | 1.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | N/A | |||
| Other Non-Current Liabilities | 123.60K | 10.02M | 10.04M | 10.60M | 20.20M | |||
| Total Non-Current Liabilities | 123.60K | 0.00 | 0.00 | 0.00 | 20.20M | |||
| TOTAL LIABILITIES | 2.99M | 24.75M | 18.04M | 17.65M | 21.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -30.70M | -28.66M | -25.12M | -20.14M | -21.10M | |||
| Additional Paid In Capital | 29.05M | 4.61M | 4.61M | 5.16M | 0.00 | |||
| Common Shares | 2.70K | 4.71M | 4.71M | 4.17M | 276.00M | |||
| Shares Outstanding | 27.06M | 26.01M | 26.01M | 26.01M | 34.50M | |||
| Tangible Book Value per Share | -0.06 | -0.74 | -0.61 | -0.42 | 7.39 | |||
| Total Shareholders' Equity | -1.65M | -19.34M | -15.79M | -10.81M | 254.90M | |||
| TOTAL LIABILITIES AND EQUITY | 1.34M | 5.41M | 2.24M | 6.84M | 276.40M | |||
| Statistics | ||||||||
| Current Ratio | 0.42 | 0.21 | 0.12 | 0.39 | 0.29 | |||
| Return On Assets (ROA) | -216.51% | -65.56% | -222.30% | -42.79% | 1.58% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | 1.71% | |||
All data in USD , ROIC based on taxRate of 0.21